- Sections
- C - Chimiemétallurgie
- C07H - Sucresleurs dérivésnucléosidesnucléotidesacides nucléiques
- C07H 19/09 - Radicaux pyrimidine avec un arabinosyle comme radical saccharide
Détention brevets de la classe C07H 19/09
Brevets de cette classe: 39
Historique des publications depuis 10 ans
|
1
|
2
|
3
|
2
|
2
|
3
|
7
|
2
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| BioSight Ltd. | 23 |
7 |
| University of Southern California | 2149 |
4 |
| CARIS Science, Inc. | 71 |
4 |
| Emory University | 1727 |
4 |
| Gilead Sciences, Inc. | 2249 |
2 |
| Janssen Pharmaceutica N.V. | 3142 |
1 |
| aRigen Pharmaceuticals, Inc. | 7 |
1 |
| The Governors of the University of Alberta a non-profit educational institution | 5 |
1 |
| Illumina, Inc. | 3544 |
1 |
| Medivir AB | 112 |
1 |
| Nippon Kayaku Kabushiki Kaisha | 1474 |
1 |
| The Research Foundation for The State University of New York | 1774 |
1 |
| Sanlugen PharmaTech Ltd. | 2 |
1 |
| Shanghai Desano Chemical Pharmaceutical Co., Ltd | 33 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3019 |
1 |
| University of Bonn | 16 |
1 |
| University of Idaho | 112 |
1 |
| University of Munster | 4 |
1 |
| Wave Life Sciences Ltd. | 227 |
1 |
| Aligos Therapeutics, Inc. | 165 |
1 |
| Autres propriétaires | 3 |